📈 Semaglutide Protocol

Educational Reference Only. Not Medical Advice.

⸻

❓What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist that mimics a naturally occurring hormone involved in:

* Appetite regulation
* Blood sugar control
* Slowing stomach emptying
* Increasing feelings of fullness

The goal is to increase the dose slowly so the body can adapt and minimize side effects.

⸻

Physician Fat Loss Titration & Strategy Protocol

 

Phase Timeline Weekly Dose Fat Loss Strategy & Clinical Action Plan
Initiation Weeks 1–4 0.25 mg Priming Phase: Zero fat loss expected. Used strictly to build gastrointestinal tolerance and establish daily protein/hydration habits.
Active Fat Loss Weeks 5–8 0.50 mg The MED Threshold: Many patients begin dropping 1–2 lbs per week here. If fat loss is consistent, stay at this dose indefinitely. Do not escalate just because the calendar says to.
Escalation 1 Weeks 9–12 1.00 mg Plateau Breaker: Deployed ONLY if fat loss stalls (fewer than 0.5 lbs per week for 3 consecutive weeks) at the 0.5 mg dose. Appetite suppression peaks significantly here.
Escalation 2 Weeks 13–16 1.70 mg Therapeutic Advanced: Used for higher metabolic resistance. Focus narrows tightly to tracking protein intake to prevent lean body mass wasting.
Max Therapeutic Week 17+ 2.4 mg

Metabolic Ceiling: The absolute maximum dose for chronic weight management. Used when lower doses fail to yield a 5% to 10% reduction in baseline body weight.


⸻

 Critical Fat Loss Protocol Additions

When managing semaglutide strictly for fat loss, physicians typically pair the medication with a rigid set of secondary directives to ensure the patient is losing adipose tissue and not just water weight or vital muscle mass:

  1. The 1.0g/lb Protein Rule: Due to the extreme appetite suppression, patients drastically under-eat. To prevent muscle wasting (sarcopenia), the protocol mandates a minimum of 0.8 to 1.0 grams of protein per pound of target body weight daily.

  2. Resistance Training Mandate: Patients must perform resistance/weight training at least 3 days per week. Without it, up to 40% of the weight lost on GLP-1 medications can come directly from lean skeletal muscle.

  3. The Plateau Checklist: Before escalating a patient to a higher, more expensive dose with more side effects, clinicians verify three things:

    • Is the patient sleeping fewer than 7 hours? (Raises cortisol, stalls fat loss)

    • Has daily water intake dropped below 80–100 oz?

    • Are they accidentally in an extreme, muscle-burning caloric deficit (fewer than 1,000 calories/day)?

  4. Maintenance/Weaning Protocol: Once target body fat percentage is achieved, physicians do not cut the medication cold turkey. The standard exit protocol involves either widening the injection window (e.g., injecting the maintenance dose every 10 to 14 days instead of every 7) or slowly micro-titrating back down the chart to prevent immediate rebound hunger.

⸻

Common Side Effects

Most side effects improve during the first few weeks.

Gastrointestinal

* Nausea ⭐ (most common)
* Vomiting
* Constipation
* Diarrhea
* Heartburn
* Acid reflux
* Burping
* Bloating
* Stomach discomfort

Appetite

* Reduced appetite
* Early fullness
* Less food “noise”

General

* Fatigue
* Mild headache
* Occasional dizziness (especially if dehydrated)

⸻

Serious Side Effects (Seek Medical Care)

Although uncommon, seek prompt medical attention for:

* Severe abdominal pain that may radiate to the back (possible pancreatitis)
* Persistent vomiting causing dehydration
* Severe allergic reaction (swelling, difficulty breathing)
* Symptoms of gallbladder disease (right upper abdominal pain, fever, jaundice)
* Severe, persistent constipation with significant abdominal pain

⸻

Tips to Reduce Side Effects

✔️ Eat slowly

✔️ Stop eating when comfortably full

✔️ Stay well hydrated

✔️ Prioritize protein

✔️ Avoid greasy or fried foods if nausea occurs

✔️ Eat smaller meals

✔️ Avoid lying down immediately after eating

⸻

Missed Dose

If a dose is missed:

* Within 5 days: Take the missed dose as soon as possible.
* More than 5 days: Skip the missed dose and resume the regular weekly schedule.

Never take two doses close together to make up for a missed injection.

⸻

Important Safety Information

Semaglutide should only be used under the guidance of a qualified healthcare professional. It is generally not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients with a history of pancreatitis, gallbladder disease, or severe gastrointestinal disorders should discuss the risks and benefits with their healthcare provider before starting treatment.

Disclaimer: This guide is intended for educational purposes only and summarizes a commonly used physician-directed titration approach. Individual dosing, monitoring, and treatment decisions should always be personalized by a licensed healthcare professional.

⸻

Works Cited

Alawadhi, A. A., et al. "LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial." BMJ Open, vol. 16, no. 4, pp. e116911. Cited by: 2

Ng, C. D. "Real-World Weight Loss Observed With Semaglutide and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE)." Current Medical Research and Opinion, vol. 41, no. 2, pp. 201–210. Cited by: 23

Sanyal, A. J., et al. "Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis." New England Journal of Medicine, vol. 392, no. 22, pp. 2105–2117. Cited by: 990